Brain Tumour Shrinks by Half After New Radioactive Therapy
University College London Hospitals NHS Foundation Trust
Paul Read was the first patient recruited in a new therapy trial for treating brain tumours
A man’s brain tumour has shrunk by half in a matter of weeks thanks to a new radioactive therapy.
The therapy, at University College London Hospitals NHS Foundation Trust (UCLH), involved injecting low levels of radioactivity directly into the tumour to kill off cancer cells.
The doctor who designed the trial said the results were “remarkable for somebody whose tumour is so aggressive”.
Surgeons first removed as much tumour as possible before implanting a small medical device, called an Ommaya reservoir, under the scalp.
The drug ATT001, which is given weekly for four to six weeks, is potent over short distances, causing lethal damage to cancer cells while sparing healthy tissue.
University College London Hospitals NHS Foundation Trust
A doctor said Mr Read’s results were remarkable given how tumour was so aggressive
The trial was designed by UCLH consultant medical oncologist and chief investigator Dr Paul Mulholland.
Because it’s to the tumour cells, it’s very at killing them.
We’ve just through [Paul’s scan results with him and his treatment scan shows a in the tumour, which is really quite for somebody whose tumour is so aggressive.
Dr said, hoped to increase the dose of and number of patients.